Virginia § 32.1-73.23 Collection of sickle cell disease case information by the Commissioner

Virginia Statutes

§ 32.1-73.23 — Collection of sickle cell disease case information by the Commissioner

Virginia § 32.1-73.23

Title 32.1Health

Ch. 2Disease Prevention and Control

Art. 22Statewide Sickle Cell Disease Registry

This text of Virginia § 32.1-73.23 (Collection of sickle cell disease case information by the Commissioner) is published on Counsel Stack Legal Research, covering Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Va. Code Ann. § 32.1-73.23 (2026).

Text

A.Using such funds as may be appropriated therefor, the Commissioner or his designee may perform on-site data collection of the records of patients having sickle cell disease at those consenting hospitals, clinics, independent pathology laboratories, and physician offices required to report information on such patients pursuant to the reporting requirements of § 32.1-73.22 in order to ensure the completeness and accuracy of the statewide sickle cell disease registry.

B.The selection criteria for determining which consenting hospitals, clinics, independent pathology laboratories, and physician offices may be subject to on-site data collection under the provisions of this section shall include (i) the expected annual number of sickle cell disease case reports from each such facility, (ii)

Free access — add to your briefcase to read the full text and ask questions with AI

A. Using such funds as may be appropriated therefor, the Commissioner or his designee may perform on-site data collection of the records of patients having sickle cell disease at those consenting hospitals, clinics, independent pathology laboratories, and physician offices required to report information on such patients pursuant to the reporting requirements of § 32.1-73.22 in order to ensure the completeness and accuracy of the statewide sickle cell disease registry.

B. The selection criteria for determining which consenting hospitals, clinics, independent pathology laboratories, and physician offices may be subject to on-site data collection under the provisions of this section shall include (i) the expected annual number of sickle cell disease case reports from each such facility, (ii) the historical completeness and accuracy of reporting rates of each facility under consideration, and (iii) whether the facility maintains its own sickle cell disease registry.

C. The Board shall promulgate regulations necessary to implement the provisions of this section.